This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at email@example.com or call 800-767-3771 ext. 9339.
Greenway Medical Technologies, Inc. recently reported that Baylor Quality Alliance has chosen Greenway to take part in its electronic health record (EHR) program.
The EHR program of Baylor Quality Alliance allows its doctor practices to consider EHR apps that fulfill their requirements. Medical practices may choose PrimeSUITE from Greenway while Baylor Quality Alliance will facilitate the working details. PrimeSUITE is currently ultilized by a few practices in the Baylor Health Care System.
Baylor Health Care System is a non-profit entity which helps a chain of acute care inpatient facilities and allied organizations that provide health care. Data submitted to the Texas Department of State Health Services reveals that Baylor Health Care System had $4.1 billion gross revenue and 2.8 million encounters with patients in fiscal 2011.
Greenway offers PrimeSuite, which is the company’s unified data base EHR and practice management offering. Several thousand health care providers use Greenway’s cloud-based or facility-based offerings.
Optimism about the growth prospects of select health care information technology service providers remains favorable under the Obama administration, which passed a Stimulus package in May 2009. The Stimulus package aimed to increase the use of EHR systems by medical practitioners.
Though the federal stimulus is winding down, the replacement market has been growing. Competition is fierce and larger competitors may benefit from the incumbency factor. Industry stalwarts such as Athenahealth (ATHN - Analyst Report) offer long-standing seamless products, which integrates inpatient and ambulatory-care systems. Allscripts Healthcare Solutions, Inc. (MDRX - Analyst Report) is another competitor in a crowded field.
Greenway carries a Zacks Rank #4 (Sell). We are more optimistic about Cerner Corporation (CERN - Analyst Report), which carries a Zacks Rank #2 (Buy) and is expected to do well.